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Abstract
Background: Increased prescription of antidepressants has been consistently associated with a decrease in suicide
rates in several countries. The aim of this study is to explore antidepressant consumption, suicide rates and
admission for depression in the Veneto Region, Italy, in order to see whether the same pattern could be detected.
Methods: Data from the Italian Ministry of Health (admissions for depression), the Pharmacy Service of a Local
Health Unit (antidepressant prescribing) and from the Epidemiological System of the Veneto region (suicide rates)
were collected from 2000 to 2005 for the Veneto region.
Results: Suicide rates did not show any marked increase but were stable in males and females. Antidepressant
prescribing increased exponentially over the period examined, whilst admissions for depression markedly
decreased. The trend for an exponential increase in antidepressant prescribing in the Veneto region is shared with
other countries and locales.
Conclusions: It is possible that the increase in antidepressant prescribing might be associated with earlier
treatment of depression, thus decreasing the likelihood of aggravation of depression.
Background
Antidepressant prescribing has risen in several countries
worldwide over the last 20 years, mainly after the intro-
duction of selective serotonin reuptake inhibitors
(SSRIs) [1,2]. This increase may be the result of better
treatment and recognition of depression [3]. However,
some concerns have been raised over the fact that anti-
depressant use may increase the risk of suicide [4]. Eco-
logical studies have shown some evidence that more
widespread antidepressant use corresponds to a decrease
in suicide rates [1], although this finding is disputed [5].
Some studies show that treating more depressed
patients with antidepressants may prevent suicides [6].
Moreover, a meta-analysis by Barbui and colleagues [7]
on observational studies, showed that use of SSRIs is
associated with a reduced risk of suicide in adults with
depression, particularly in people aged 65 or over.
Other than suicide and antidepressant prescribing, the
pattern of hospital admissions for depression can be
another valid indicator when exploring trends in the
prevalence of depression and may shed some light on
the relationship between suicide rates and depression. In
one of the few ecological studies on the topic, Vyssoki
and colleagues found that increased hospital admissions
for depression were linked to a decrease in suicide rates
in Austria between 1989 and 2008 [8]. These findings
are in line with those of Roy [9], who found that
patients who commit suicide at their first attempt had
had fewer admissions for depression. It appears that
hospital admissions may have a protective effect on sui-
cide rates. Hospital admissions rates can also be consid-
ered a proxy for depression severity [10,11] and can
offer some insight on the trend of severely depressed
people over time.
Evidence shows that depression is a major cause of
suicide [12], and that severe depression is associated
with higher suicide risk [13]. The time trend of hospital
admissions for depression has been investigated in sev-
eral studies [2,14,15]. Shajan and colleagues [15] found
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increased in males between 1980 and 1995 in Scotland;
however, Walsh [14] found that there was no change in
admissions in males in Ireland between 1975 and 1995.
Guaiana and colleagues [2] found that admissions in
Italy did not decline between 1986 and 1998. Analysing
combined trends for hospital admissions for depression,
suicide and antidepressant prescribing can offer some
insight on the impact of antidepressant prescribing on
admissions for depression and suicide rates. This analy-
sis has been carried out for some European countries
[2,5]. However, only few studies have focused on
selected regions of a country. Italy is a diverse country
with some notable differences between the North and
the South [16]. Consequently, trends in the whole of
Italy may not be representative of a specific region.
Veneto is a north-east Italian region with a population
of about 5 million people [16]. It has an average yearly
numbers of suicides of 327 [17]. Half of suicides occur
in people aged 52 or older [17]. Males account for
three-quarters of suicides [17]. The most commonly
used method is hanging [17].
T h ea i mo ft h i ss t u d yw a st oe x a m i n et h et r e n di n
admissions for depression, antidepressant prescribing
and suicide in this large Italian region, with a view to
investigating how the pattern of antidepressant sale is
related to suicide and admissions for depression, consid-
ered a proxy for depression severity.
Methods
Data on admissions for depression were collected by the
Italian Health Ministry internet database on Hospital
discharges (Scheda di Dimissione Ospedaliera (SDO)).
The official database is freely available on the internet
[18], and includes data from 2000 to 2005. For every
patient discharged from an Italian hospital, an official
discharge form (the SDO) needs to be completed and
sent to the Ministry of Health. The SDO includes demo-
graphic data (age, sex, region of discharge) and Interna-
tional Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) discharge diagnosis. Data
were selected for the Veneto region and for the follow-
ing ICD-9-CM diagnostic codes: 296.20 to 295.26
(major depression single episode), 296.30 to 296.36
(major depression recurrent episode), 296.82 (atypical
depressive syndrome), 298.0 (depressive psychosis),
300.4 (neurotic depression), 311 (depressive disorder,
not otherwise classified). Data on age were grouped in
the following age bands: 0-14 years of age, 15-64, and
65 and over. There is no specific validation study of the
SDO. However, the Italian Ministry of Health runs its
own validation audit and it publishes the results in their
annual report [19]. A raw rate of admission per 100,000
population was calculated for each age band and sex, for
each year, as well as an age-standardised total rate of
admissions for depression per 100,000 population, for
each year and sex. The standard population is the 2011
Census population.
We also collected data on psychiatric bed availability
in Veneto Region from 2000 to 2005, from the ISTAT
statistical yearbook [16].
Data on antidepressant (AD) prescriptions were col-
lected by the pharmacy service of one of the Local
Health Units (LHUs) in Veneto, from 2000 to 2005. No
data is available after 2005. Data were available for 12
o u to f2 1L H U s .T h ep o p u l a t i o no f1 2L H U sr e f e r st o
all inhabitants of the LHU area with no further restric-
tions. The distribution of classes of ages and gender is
almost the same for the 12 LHUs and the Veneto region
as a whole (percentage of children aged 0-14 years:
13.8% vs 13.9%, percentage of older people over 65
years: 19.8% vs 19.5%, percentage of females: 51.2 vs
51.1). Furthermore, prescriptions of antidepressants in
the 12 LHUs are very similar to that of the Veneto
region (in 2005 then number of boxes of antidepressants
prescribed were 0.46 vs 0.44). Based on these assump-
tions, the sample of 12 LHUs can be considered as
representative of the whole Veneto region. For each AD,
the number of packages sold was converted into defined
daily doses (DDDs) per 1,000 inhabitants per day (DDD/
1,000/day). The DDD is the international unit of drug
utilisation approved by the World Health Organization
for drug use studies [20]. The DDD is a theoretical unit
of measurement defined as the assumed average mainte-
nance daily dose for a drug, used for its main indication
in adults. The DDD/1,000/day indicates how many peo-
ple per 1,000 of the population have in theory received
a standard dose (that is, the DDD) of a particular medi-
cation or category of medication daily.
Data on numbers of suicide deaths according to the
Ninth Revision of the Italian International Classification
of Diseases (ICD-IX) in each sex and age group and
estimates of the resident population in Veneto were col-
lected from the regional epidemiological system (Sistema
Epidemiologico Regione Veneto (SER)), which is the
local government-funded regional statistical office, from
2000 to 2005. Data were age standardised by the SER
for both sexes.
A statistical model using ordinary least squares linear
regression was employed, based on the model developed
by Preti and Miotto [21]. The model was used in the
present study to test for changes over time in suicide
rates and admission rates for depression. Rates were the
dependent variable and years were the independent vari-
able. Linear regression analysis of rates over 6 years
(2000 to 2005) was performed. A two-tailed t test was
also performed to test for the hypothesis of a significant
slope.
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age strata across the time period examined (2000-2005)
was calculated for AD DDD and admissions for depres-
sion rates. We also calculated a Spearman r correlation
coefficient for AD DDD and suicides rates for each sex,
between 2000 and 2005 and a Spearman r correlation
coefficient for admissions for depression and suicide
rate, for each sex, between 2000 and 2005. SPSS for
Windows V. 19 (SPSS, Chicago, IL, USA) was used to
perform all the calculations.
Results
Hospital admissions for depression and psychiatric beds
We performed a separate analysis of admissions for each
age band and sex for the years 2000 to 2005. The pat-
tern of admission for the age band 0-14 males was quite
erratic, with a drop in 2001 and a steady increase from
2002 to 2005. Females aged 0 to 14 also showed an
erratic pattern with a decline in admissions from 2000
to 2001, followed by a drop in 2002, a peak in 2004 and
another decline in 2005. It is very likely that this erratic
pattern reflects the small numbers of admissions. The
linear regression model showed no significant trend
both for males (slope -0.036, 95% CI -0.312 to 0.384, SE
0.125, adjusted R
2 -0.225, F 0.082, P = 0.788) and for
females (slope -0.069, 95% CI -0.544 to 0.406, SE 0.171,
adjusted R
2 0.201, F 0.162, P = 0.708).
The 15-64 age band showed, instead, a consistent
trend toward reduction in admission between 2000 and
2005, for males (slope -1.465, 95% CI -1.837 to -1.093,
SE 0.134, adjusted R
2 0.960, F 119.642, P = 0.0001) and,
to a higher degree, for females (slope -6.379, 95% CI
-7.291 to -5.466, SE 0.329, adjusted R
2 0.987, F 376.559,
P = 0.0001). People aged 65 or older also showed a
downward trend. Admissions for males over 65
increased from 2000 to 2001 and then steadily decreased
(slope -8.994, 95% CI -15.247 to -2.741, SE 2.252,
adjusted R
2 0.749, F 15.948, P = 0.016). Female admis-
sions showed a decreasing trend from 2000 to 2005
(slope -22.508, 95% CI -30.518 to -14.497, SE 2.885,
adjusted R
2 0.923, F 60.861, P = 0.001).
The total age-standardised admission rates for depres-
sion for each sex are shown in Table 1. Overall, the
admissions for depression declined both in males and in
females from 2000 to 2005. The number of beds in the
Veneto region changed from a maximum of 796 in 2000
to a minimum of 733 in 2003. The number of beds rose
again up to 763 in 2004 and 757 in 2005.
Antidepressant drugs prescribing
The analysis shows that AD consumption in the Veneto
region increased exponentially from 2000 to 2005, both
for males and for females (see Figure 1).
I ft h ed a t ai sb r o k e nd o w nb ya g e( s e eT a b l e2 ) ,t h e r e
is an increased use of antidepressants on moving to the
higher age bands. This finding is consistent among
males and females for all the years examined. AD pre-
scribing is at least double that in males and females
over 65 compared to people aged 15-64 years. Looking
at the prescribing trend, we find that in the 0-14 age
band AD consumption steadily increased between 2000
and 2005, both in males and in females. Looking at the
15-64 age band, we find that AD prescription increased
exponentially from 2000 to 2005 with an almost identi-
cal trend in males and females. Males, however, were
prescribed less DDD than females. The 65 and over age
band shows the same trend as the 15-64 year olds, with
an exponential increase in AD DDD with almost identi-
cal trends for males and females, and males prescribed
less DDD than females.
Suicides
Suicide rates per 100,000 population in Veneto showed
some minor changes in males over the period examined,
with a maximum of 12.3 in 2002 and a minimum of 9.7
in 2003. The rate of suicide did not change markedly in
females, oscillating between a maximum of 3.6/100,000
in 2000 and 2001 and 3.1/100,000 in 2004 and 2005
(see Figure 1). The linear regression model did not yield
Table 1 Age-standardised admission rate per 100,000
population for depression for each sex, 2000-2005
Males Females
2000 20.92 46.52
2001 21.42 44.96
2002 20.94 42.26
2003 20.51 38.94
2004 20.33 37.51
2005 19.54 35.13
Figure 1 Suicide rates (bars) and antidepressant prescribing
(line) among males and females in Veneto from 2000 to 2005.
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-0.269, 95% CI -0.863 to 0.326, SE 0.214, adjusted R
2
0.103, F 1.572, P = 0.278) or for females (slope -0.103,
95% CI -0.242 to 0.036, SE 0.05, adjusted R
2 0.393, F
4.235, P = 0.109).
Correlation
The Spearman r correlation coefficients for AD DDD
and admission rates for depression are shown in Table
3.
It appears that there is a high inverse correlation
between antidepressant prescribing and admissions for
depression for the age strata 15-64 and 65+, both in
males and in females. No significant correlation was
found between antidepressant prescribing and admis-
sions for depression in the age strata 0-14, for either
sex.
The Spearman r correlation coefficients for AD DDD
and age-standardised suicide rates are shown in Table 4.
There is no correlation between suicide rates and AD
DDD between 2000 and 2005, for either sex.
The Spearman r correlation coefficients for total
admissions for depression and age-standardised suicide
rates for each sex are shown in Table 5. There is no
correlation between suicide rates and admissions for
depression between 2000 and 2005, for either sex.
Discussion
The present study aimed to assess trends in hospital
admissions for depression, considered as a proxy for
depression severity, and to relate these trends with anti-
depressant prescription and suicide rates in the region
of Veneto between 2000 and 2005. Additionally, suicide
rates were analysed in order to assess a possible link
between antidepressant use and suicide. Essentially, we
found a marked decline in admissions for depression,
with no major change in psychiatric bed availability, an
exponential increase in antidepressant prescribing, and
no change in suicide rates. Also, the results show that
the trend of suicide rates does not correlate with the
changes in admission rates for depression. It also
appears that the increase in AD prescribing does not
correlate with changes in suicide rates. It may be possi-
ble that the relationship between AD prescribing and
suicide rates may work only for some age strata. Older
people use antidepressants far more than younger peo-
ple. This finding has been confirmed for the whole of
Italy [22]. Unfortunately, we have no information on
suicide rates divided by age. It appears that antidepres-
sants are very effective in preventing suicide among
older people [7]. We also have no data on the propor-
tion of SSRIs that make up the total number of ADs
prescribed. However, we can say that it is likely that the
majority of antidepressants prescribed in Veneto are
SSRIs and newer ADs. The study by Guaiana and collea-
gues [2] showed that SSRIs and newer ADs had an
exponential increase in prescription, whilst the prescrip-
tion of older tricyclic ADs did not change. Also, two
other recent studies performed in different Italian
regions [23,24] showed that t h ep r e v a l e n c eo fS S R Iu s e
had markedly increased. The first and most striking
finding is the sharp decline of hospital admissions for
depression. This decrease affected both the age strata
16-64 and 65+ age band, as well males and females. The
data relating to the 0-14 age strata are not reliable due
to the small numbers involved. This finding is at odds
with that of Vyssoki and colleagues [8], who found that
an increase in hospital admissions for depression was in
Table 2 Defined daily doses/1,000/day for
antidepressants (ADs) divided by age and sex
Males Females
0-14 15-64 65+ 0-14 15-64 65+
2000 0.05 3.63 12.51 0.02 7.60 22.73
2001 0.11 8.76 20.85 0.11 18.56 39.75
2002 0.17 11.05 25.67 0.18 23.58 48.99
2003 0.22 12.34 28.06 0.28 25.99 54.39
2004 0.31 14.60 31.35 0.4 30.43 60.94
2005 0.35 15.12 30.61 0.53 31.73 59.62
Table 3 Spearman r correlation coefficients and P values
for antidepressant defined daily doses (AD DDD) and
admissions rates for depression
Admissions for depression and DDD Spearman r/P value
Males aged 0-14 -0.08 (NS)
Females aged 0-14 -0.3 (NS)
Males aged 15-64 -1 (P < 0.01)
Females aged 15-64 -1 (P < 0.01)
Males aged 65+ -0.94 (P < 0.05)
Females aged 65+ -0.89 (P < 0.05)
NS = not significant.
Table 4 Spearman r correlation coefficients and P values
for antidepressant defined daily doses (AD DDD) and
suicide rates
AD DDD and suicide rates Spearman r/P value
Males -0.66 (NS)
Females -0.61 (NS)
NS = not significant.
Table 5 Spearman r correlation coefficients for
admissions for depression and suicide rates for each sex
Total admissions and suicide rates Spearman r/P value
Males 0.66 (NS)
Females 0.62 (NS)
NS = not significant.
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eral possible explanations to the findings in the 16-64
and 65+ age bands. In theory, fewer hospital admissions
m a yj u s tr e f l e c tad e c r e a s ei nt h eg e n e r a lp r e v a l e n c eo f
depression, or a decrease in recognition of depression,
or both. There is no evidence to suggest either. On the
contrary, worldwide data have repeatedly documented
an increase in the incidence and/or awareness of depres-
sion both amongst the general population and medical
practitioners [5]. Moreover, both trends would be at
odds with our second finding of an impressive increase
in antidepressant prescription in the same region at the
same time. Another possibility is that the observed
decrease in hospital admission merely reflects a decrease
in bed availability. This however does not seem to be
the case as the number of beds did not decline. The
most likely explanation of the observed decline in hospi-
tal admissions for depression between 2000 and 2005 is
that depression became better diagnosed, and therefore
better treated. This notion becomes particularly salient
when considering our next finding of an approximately
fivefold increase in antidepressant use in the same per-
iod. It is most plausible that the observed increase in
antidepressant prescribing reflects a better effort in
recognising depression, and therefore earlier and more
effective treatment. The benefits of early intervention
have been widely documented [25], resulting in the
shortening of the depressive episode. If, as mentioned
above, hospital admissions are a valid indicator of
depression severity [10,11], then it is arguable that the
decrease in hospital admissions is directly linked to an
increase in effective prescription of antidepressants. It is
of note that a worldwide increase in the prescription of
antidepressants has been observed over the last 10-15
years [5].
T h e r eh a v eb e e ns o m er e p o r t ss h o w i n gt h a ta d m i s -
sions for depression increased or did not change
[2,14,15]. Shajahan [15] reported that admissions
increased in males in Scotland. They hypothesised that
this may be due to increased recognition of depression
or an increase in the health-seeking behaviour of males.
The study by Shajahan refers to an earlier timeframe
(1980-1995). It is possible to hypothesise that since the
late 1990s, there has been an increased awareness of
depression, possibly leading to an increase in the num-
ber of the people treated with antidepressants, which
eventually led to an overall decrease in depression sever-
ity and therefore in admissions for depression. The
increased awareness for depression may likely have hap-
pened in primary care scenarios. It appears that general
practitioners prescribe more and more ADs in some
European regions [8]. To corroborate this hypothesis,
Munoz-Arroyo and colleagues [26] found that prescrip-
tion of antidepressants by general practitioners doubled
in Scotland from 1992 to 2000. Also, the studies by
Walsh [14] and Guaiana et al. [2], examining admissions
in Ireland and in Italy, respectively, referred to an earlier
t i m e f r a m e .O u rh y p o t h e s i si st h a tt h e r eh a sb e e nat i m e
lag between increased prescription of antidepressants
and reductions in admissions for depression. In Italy,
antidepressant prescribing has increased exponentially
only since 1995 [2]. We hypothesise that it may have
taken some years to see an effect on depression and
admissions for depression.
A l s o ,i ti so fi n t e r e s tt on o t et h a tt h ed e c r e a s ei n
admissions for depression is not associated with change
in suicide rate, as we found no correlation between
admissions for depression ands u i c i d er a t e s ,f o rb o t h
sexes. Our final finding is that overall suicide rates
remained unchanged during the period under examina-
tion, in spite of the observed exponential increase in use
of antidepressants. If antidepressants were associated
with an increase in suicide rates, as pointed out by
Healy and colleagues [4], there would have been an
increase in suicide rates, which did not happen. Vichi
and colleagues examined suicide rates in Italy between
1980 and 2002 [27]. They concluded that the decline in
suicide rates was possibly a consequence of the decrease
in the incidence of mental disorders as a result of the
development of an integrated and community-based
mental health system, which in turn may have led to
decreased suicide rates as a consequence of early detec-
tion of mental disorders, including depression. AD pre-
scribing may be part of this picture, as earlier detection
of mental disorders may have led to an increase in AD
prescribing. Our findings are more in line with the data
examined by Isaacson and colleagues [5,6], and Barbui
and colleagues [7] where suicide rates showed an oppo-
site trend to antidepressant prescribing. Also, Khan and
colleagues [28] showed that SSRIs do not induce suicide
more than other ADs or even placebo. Regardless, our
study failed to find any argument suggesting that an
increase in antidepressant use is associated with
increased risk of suicide.
The present study suffers from some limitations, how-
ever. First we assumed that all antidepressants are pre-
scribed and used for depression. This is not entirely
true, as antidepressants are increasingly used for anxiety
disorders as well, and this is the case in Italy [29]. Anxi-
ety disorders are at least as prevalent as depression.
Both types of disorders are highly comorbid. Our data-
base does not make it possible to find out the specific
disease that required the prescription of the antidepres-
sant. However, since anxiety and depression are closely
intermingled, the former often being an indicator of the
severity of the latter and vice versa [30], this limitation
does not necessarily invalidate our main conclusions.
Secondly, data on antidepressant prescribing does not
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L H U s .W eh a v ea s s u m e dt h a tt h ed a t ac a nb ee x t e n d e d
t ot h ew h o l er e g i o nb u tw ec a n n o tr u l eo u tap o s s i b l e
bias in data collection. Also, the study covers a relatively
limited period of time; only 6 years. Nevertheless, clear
trends can be seen. Thirdly, we cannot exclude the pos-
sibility that that the downward trend in hospital admis-
sions for depression in Veneto and in Italy could be
part of a broader picture, where admissions for mental
health problems as a whole are decreasing. Moreover,
the DDD only reflects prescription and not current
usage. It is not possible to take for granted that all peo-
ple who receive a prescription will use it. It must also
be said that the reliability of data on admissions, sui-
cides and DDD may be questioned, as happens for any
large-scale data collection. Another point to consider is
that suicide is not only linked to depression but also to
schizophrenia, bipolar disorder and substance misuse
[31-33]. Our data do not include admissions for those
conditions. Findings may have been different if we had
included admissions for those mental disorders. Finally,
the naturalistic design of this analysis is by definition
subject to ecological fallacy, and therefore no causal
relationships can be definitely established.
Conclusions
In spite of the limitations outlined above, we conclude
that the marked increase observed in prescription of
antidepressants has been attended by a striking decrease
in hospital admissions for depression in the same per-
iod. The exponential change in antidepressant use was
not accompanied by any relevant change in suicide
rates. Further studies will be required to refute or corro-
borate these findings.
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